These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6086470)

  • 41. Immunity, herpes simplex virus, and cervical carcinoma.
    Mumford DM; Kaufman RH; McCormick N
    Surg Clin North Am; 1978 Feb; 58(1):39-54. PubMed ID: 205961
    [No Abstract]   [Full Text] [Related]  

  • 42. Herpes simplex virus. An expanding relationship to human cancer.
    Smith JW
    J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
    [No Abstract]   [Full Text] [Related]  

  • 44. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 45. A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero.
    Adam E; Kaufman RH; Adler-Storthz K; Melnick JL; Dreesman GR
    Int J Cancer; 1985 Jan; 35(1):19-26. PubMed ID: 2981778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
    Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
    Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
    [No Abstract]   [Full Text] [Related]  

  • 48. Herpes virus-related antigens in herpes simplex virus type 2-transformed cells in the course of cervical carcinoma.
    Christenson B
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1345-52. PubMed ID: 6299751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of herpes simplex-associated antigens and antibodies in patients with cervical carcinoma in Buenos Aires.
    Teyssié AR; Ayerra de Holstein B; Alonio L; Distéfano A; Lucero J; Pasqualini RS; de Torres RA
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):123-7. PubMed ID: 6258793
    [No Abstract]   [Full Text] [Related]  

  • 50. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
    Thomas DB; Rawls WE
    Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk.
    Jha PK; Beral V; Peto J; Hack S; Hermon C; Deacon J; Mant D; Chilvers C; Vessey MP; Pike MC
    Lancet; 1993 May; 341(8853):1116-8. PubMed ID: 8097804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays.
    Møller-Larsen A
    J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HSV-IgA serum antibodies in cervical intraepithelial neoplasia and invasive cancer patients, and in their spouses: a case control study.
    Gupta MM; Jain R; Parashari A; Singh V; Satyanarayana L
    APMIS; 1992 Jul; 100(7):598-604. PubMed ID: 1322678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective study on the relationship between cervical neoplasia and herpes simplex type 2 virus. III. Presence of herpes simplex type-2 antibody in sera of subjects who developed cervical neoplasia later in the study.
    Krcmár M; Suchánková A; Kanka J; Vonka V
    Int J Cancer; 1986 Aug; 38(2):161-5. PubMed ID: 3015805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of antibodies against herpes simplex and adenovirus in oral and cervical cancer patients--a preliminary report.
    Kumari TV; Shanmugam J; Prabha B; Vasudevan DM
    Indian J Med Res; 1982 Apr; 75():590-2. PubMed ID: 6286474
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognostic significance of herpes simplex virus antibody status in women with cervical intraepithelial neoplasia (CIN).
    Coleman DV; Morse AR; Beckwith P; Anderson MC; Gardner SD; Knowles WA; Skinner GR
    Br J Obstet Gynaecol; 1983 May; 90(5):421-7. PubMed ID: 6303385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [HLA-SD-antigens in cervix cancer and recurrent herpes genitalis patients (author's transl)].
    Dostal V; Mayr WR
    Osterr Z Onkol; 1977; 3(5-6):119-21. PubMed ID: 193077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
    Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
    Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
    Heise ER; Kucera LS; Raben M; Homesley H
    Cancer Res; 1979 Oct; 39(10):4022-6. PubMed ID: 225014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.